Literature DB >> 10572079

Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.

U Nowak-Göttl1, R Sträter, A Heinecke, R Junker, H G Koch, G Schuierer, A von Eckardstein.   

Abstract

Ischemic stroke is a rare event in childhood. In approximately one third of cases no obvious underlying cause or disorder can be detected. We investigated the importance of genetic risk factors of venous thromboembolism in childhood or stroke in adulthood as risk factors for spontaneous ischemic stroke in children. One hundred forty-eight Caucasian infants and children (aged 0.5 to 16 years) with stroke and 296 age-matched controls from the same geographic areas as the patients were analyzed for increased lipoprotein (a) [Lp(a)] levels >30 mg/dL; for the presence of the factor V (FV) G1691A mutation, the prothrombin (PT) G20210A variant, and the TT677 genotype of methylenetetrahydrofolate reductase (MTHFR); and deficiencies of protein C, protein S, and antithrombin. The following frequencies (patients v controls), odds ratios (ORs), and confidence intervals (CIs) of single risk factors were found: Lp(a) >30 mg/dL (26.4% v 4.7%; OR/CI, 7.2/3.8 to 13.8; P <.0001), FV G1691A (20.2% v 4%; OR/CI, 6/2.97 to 12.1; P <.0001), protein C deficiency (6% v 0.67%; OR/CI, 9.5/2 to 44.6; P =.001), PT G20210A (6% v 1.3%; OR/CI, 4.7/1.4 to 15.6; P =.01), and the MTHFR TT677 genotype (23.6% v 10.4%; OR/CI, 2.4/1.53 to 4.5; P <.0001). A combination of the heterozygous FV G1691A mutation with increased Lp(a) (n = 11) or the MTHFR TT677 genotype (n = 5) was found in 10. 8% of cases, but only 0.3% of controls (OR/CI, 35.75/4.7 to 272; P <. 0001). Increased Lp (a) levels, the FV G1691A mutation, protein C deficiency, the prothrombin G20210A variant, and the MTHFR TT677 are important risk factors for spontaneous ischemic stroke in childhood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572079

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Clinical implications of elevated lipoprotein(a).

Authors:  A von Eckardstein; G Assmann
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

2.  Homozygosity for factor V Leiden mutation and ischemic stroke: two case-reports and review of the literature.

Authors:  Achim Allroggen; Ralf Dittrich; Martin Ritter; Rainer Dziewas; Ralf Junker; Darius G Nabavi
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 3.  Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations.

Authors:  Lauren A Beslow; Lori C Jordan
Journal:  Childs Nerv Syst       Date:  2010-07-13       Impact factor: 1.475

4.  Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Authors:  Marian C Cheung; John J Albers; Hal Kennedy; Hiroshi Deguchi; Darlene J Elias; Patricia M Averell; John H Griffin; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

Review 5.  Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research.

Authors:  Courtney A Lyle; Timothy J Bernard; Neil A Goldenberg
Journal:  Semin Thromb Hemost       Date:  2011-12-20       Impact factor: 4.180

Review 6.  The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.

Authors:  Ilona Kopyta; Beata Sarecka-Hujar; Joanna Sordyl; Ryszard Sordyl
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

Review 7.  Stroke in children.

Authors:  Sheffali Gulati; Veena Kalra
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

Review 8.  Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.

Authors:  Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

9.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children.

Authors:  Neil A Goldenberg; Timothy J Bernard; Jasper Hillhouse; Jennifer Armstrong-Wells; Jeffrey Galinkin; Rhonda Knapp-Clevenger; Linda Jacobson; Santica M Marcovina; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.